The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000L.
Cytiva announced on June 24, 2020 that it has completed a renovation of its Fast Trak cGMP contract biomanufacturing and process development site in Marlborough, MA.
The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000, according to a company press release. The site offers technical support and single-use biomanufacturing expertise to biotechnology companies looking for assistance in bringing therapeutics to market.
“Biotechnology companies are increasingly outsourcing their manufacturing, whether to access expertise, capacity, or both,” said Olivier Loeillot, senior vice-president, BioProcess at Cytiva, in the press release. “Our upgraded Fast Trak cGMP facility will provide our customers, particularly the small to mid-size companies, with the services and expertise needed to help expedite their processes and get to market faster.”
Source: Cytiva
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.